Panacea Biotec Limited (NSE:PANACEABIO)

Panacea Biotec Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 23, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	32,405	7,445	6,643	9,077	10,958	6,692
Market Cap Growth	149.31%	12.08%	-26.82%	-17.16%	63.75%	-44.84%
Enterprise Value	30,806	5,776	3,942	15,905	16,321	13,480
Last Close Price	529.05	121.55	108.45	148.20	178.90	109.25
PE Ratio	-	-	-	0.84	-	-
PS Ratio	5.76	1.33	1.44	1.37	1.75	1.23
PB Ratio	3.91	0.89	0.79	1.04	-4.73	3.42
P/TBV Ratio	4.06	0.94	0.82	1.08	-	4.14
P/FCF Ratio	-	-	-	-	12.91	-
P/OCF Ratio	-	-	-	-	10.28	-
EV/Sales Ratio	5.47	1.03	0.86	2.40	2.61	2.48
EV/EBITDA Ratio	-	-	-	-	18.70	15.65
EV/EBIT Ratio	-	-	-	-	38.19	31.40
EV/FCF Ratio	-	-	-	-	19.23	-
Debt / Equity Ratio	0.03	0.03	0.02	0.04	-3.54	3.79
Debt / EBITDA Ratio	2.17	-	-	-	9.37	8.62
Debt / FCF Ratio	-	-	-	-	9.65	-
Asset Turnover	-	0.45	0.30	0.45	0.49	0.39
Inventory Turnover	-	1.21	1.22	1.36	1.27	1.37
Quick Ratio	-	0.70	0.83	0.82	0.41	0.27
Current Ratio	-	1.57	1.71	1.28	1.14	1.51
Return on Equity (ROE)	-	-0.18%	-3.94%	335.95%	-	-69.18%
Return on Assets (ROA)	-	-2.06%	-4.24%	-2.06%	2.08%	1.94%
Return on Capital (ROIC)	-1.82%	-3.01%	-7.26%	-4.05%	3.50%	2.78%
Return on Capital Employed (ROCE)	-	-	-	-	5.90%	4.60%
Earnings Yield	-0.24%	-0.16%	-5.00%	118.79%	-13.48%	-29.03%
FCF Yield	-	-10.45%	-69.76%	-13.33%	7.75%	-5.55%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.